CONTACT US
Life Science Partners discuss the FDA approved 23andMe DNA testing kit for breast cancer BRCA1 and BRCA2, and its effect on the biotech industry.

At-Home Genetic Testing Goes Beyond Just DNA

   

TechTalk looks at 23andMe’s DNA test-taking kit and its recent approval by the FDA to scan for certain breast cancer genes. We examine the possibilities and limitations, where the market is headed, and what it means for the biotech industry and its business advisors.


Transcript

Dave Plaskow: Hello and welcome to EisnerAmper’s technology podcast series. With more than 500 technology clients, we’re always interested in the latest industry trends and developments as well as any related business and accounting opportunities and challenges. I’m your host Dave Plaskow and with us today is Dave Katz, Senior Manager in EisnerAmper’s Technology and Life Sciences Practice. It’s another episode of TechTalk. Today’s episode is on a mail-in DNA kit that can screen for breast cancer genes. Hi Dave.

Dave Katz: Hi Dave, how are you?


More Podcasts in This Series
Lessons Learned from the Theranos Dissolution

EisnerAmper’s Technology and Life Sciences practice talks about the Theranos dissolution, and what took them from biotech unicorn to dissolution. Investors must use due diligence and consider a company's internal controls before investing in companies with high valuations.


Ride Sharing Capped in NYC

EisnerAmper's Technology podcast series discusses the proposed New York City Council cap on the number of ridesharing vehicles such as Lyft and Uber in Manhattan to ease congestion. How will this cap change Uber's valuation, and what is the economic hit to the taxi industry?


New Cryptocurrency Focuses on Price Stability

This episode of the Dave & Dave Show discusses new cryptocurrency technology from the fintech startup company Circle, called USD Coin. This cryptocurrency ties itself to the U.S. Dollar, therefore eliminates some volatility that comes with crypto mining and Bitcoin.



John Pennett has public accounting experience with a strong emphasis on life sciences companies. Member New Jersey Society of Certified Public Accountants and New Jersey Technology Council and advisory board of eLabs.

Contact John

* Required